Results presented here showed intra-articular injections of platelet-rich plasma may be inferior to corticosteroid injections for treatment of mild to moderate knee osteoarthritis. “The take-home ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis ...

Swiss pharma major Novartis has discontinued development of its experimental treatment QUC398 for knee osteoarthritis, ending ...

The Arthritis Knee Pain Centers (AKPC) and Dr. John Rush, its owner and Chief Executive Officer, face False Claims Act ...

The Department of Health - Abu Dhabi (DoH), has successfully completed a groundbreaking clinical trial in Abu Dhabi, in ...

A Certified Athletic Trainer Unveils the Ageless Knees Program—A Non-Invasive, At-Home Solution That Targets Femoral Nerve ...

MSK Doctors has released a new report detailing the positive impact that Arthrosamid has had on recent knee osteoarthritis patients, exploring the innovative hydrogel injection treatment in depth.

DelveInsight's “Musculoskeletal Pain Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

Osteoarthritis is a common chronic health condition that is characterised by joint pain and restricted movement. The main ...

Primary total hip and total knee replacements are among the most common and successful orthopedic procedures worldwide. These ...

With Japan’s rapidly aging population, the prevalence of knee osteoarthritis is expected to rise. This has led to an increased demand for non-surgical treatment options, such as knee hyaluronic acid ...

Exercise therapy is suggested as a first-line treatment to improve joint pain and loss of function caused by osteoarthritis ...